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CD4+ T helper and CD8+ cytotoxic T lymphocyte responses are believed to play an important role in the control of primary HIV and SIV
infection. However, the role of these cells in macaques acutely infected with SHIVsf162p3 has not been well characterized. In this study, ten adult
rhesus macaques were intravaginally infected with SHIVsf162p3, and antigen-specific cytokine responses to SHIV-Tat, Nef, Gag and Env peptide
pools were examined through 70 days post inoculation (p.i.) using ELISPOT and/or cytokine flow cytometry (CFC). Peak plasma viral replication
occurred between 14 and 21 days p.i. followed by low to undetectable plasma viremia by 70 days of infection in most macaques. Although some
animals had strong virus-specific cellular immune responses, many had weak or minimal responses that did not correlate with the post peak
decline in plasma viremia.
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macaqueIntroduction
Control of plasma viremia in the acute stage of human
immunodeficiency virus (HIV) and simian immunodeficiency
virus (SIV) infection is temporally associated with the
emergence of CD8+ cytotoxic T cell (CTL) responses (Borrow
et al., 1994; Koup et al., 1994; Kuroda et al., 1999; Reimann
et al., 1994). Moreover, depletion of CD8+ cells in macaques
in primary SIV infection results in prolonged peak viremia,
and CD8+ cell depletion in chronic SIV infection results in
increased levels of plasma viremia, both of which are reversed
coincident with the reappearance of circulating CD8+ cells
(Schmitz et al., 1999). Thus, it is currently believed that virus-
specific CD8+ T cells are responsible for the initial control of
peak plasma viremia in primary HIV and SIV infection.
SHIVsf162p3 has been reported to mimic natural HIV-1
infection in terms of CCR5 utilization, sustained viral replication
and gradual CD4+ loss in peripheral blood followed in some⁎ Corresponding author. Fax: +1 985 871 6510.
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inoculated with high doses (Harouse et al., 2001). However,
following mucosal inoculation with a low intravaginal dose (300
TCID50) of SHIVsf162p3, most animals appear to “control” the
infection, with peak viremia occurring between 14 and 21 days
after infection followed by low to undetectable (<125 RNA
copies/ml) viral loads in blood within 90 days of infection
(Veazey et al., 2003a, 2003c). Whether cell mediated immune
responses are associated with this control as they appear to be in
SIVor HIV infection is not well defined. The present study was
designed to determine whether the emergence or magnitude of
SHIV-specific cytokine responses as detected by ELISPOT or
cytokine flow cytometry (CFC) correlated with the reduction in
viral loads in individual macaques infected with SHIVsf162p3.
Results
Viremia
In two separate experiments, ten rhesus macaques were
vaginally infected with 300 TCID50 SHIVsf162p3. All but one
Fig. 1. Plasma viral RNA levels from all SHIVsf162p3 inoculated animals. Ten
animals became infected while three (T887, EV63 and AA41) did not. Data
shown are from the day of inoculation (day 0) through 84 days post inocu-
lation (p.i.). Note that viral loads were undetectable in 9 out of 10 animals by
84 days p.i.
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additional Chinese macaques were similarly intravaginally
inoculated, but did not get infected as evidenced by
consistently undetectable plasma viremia and absence of
virus-specific cellular immune responses, and these animals
were used as concurrent controls for subsequent samplings. In
infected animals, peak plasma viral replication (log10 5.5–8.0)
was detected between 14 and 21 days post inoculation (p.i.).
Viral loads declined in all infected animals thereafter except
for FA87, whose viral load was maintained at higher levels
(log10 6.0) through day 70 p.i. The remaining 9 infected
macaques controlled viral replication to undetectable levels
(<125 RNA copies/ml) at least transiently, between 42 and 84
days p.i. (Fig. 1).
Changes in CD4+ and CD8+ T cells in peripheral blood
All infected animals experienced transient lymphopenia
corresponding with the onset of viremia. The absolute number
of CD4+ and CD8+ T lymphocytes decreased significantly
during the first 2 weeks of infection in infected macaques with a
mean value of 1106 (day 0) vs. 629 (day 14 p.i.) CD4+ cells/μl
of blood, and 827 (day 0) vs. 452 (day 14 p.i.) CD8+ cells/μl
blood (p=0.012 and 0.014 for CD4 and CD8 respectively)
(Fig. 2A). However, absolute numbers of CD4+ and CD8+
T cells rebounded to near (CD4+) or slightly above (CD8+) pre-
infection levels by 21 days of infection and remained fairly
stable thereafter (Fig. 2A). Persistently percentages of CD4+
cells resulted in increased percentages of CD8+ T cells after day
14 p.i., which remained at higher levels compared to baseline
thereafter (Fig. 2B). The uninfected animals maintained
relatively stable numbers and percentages of both CD4+ and
CD8+ T cells throughout 70 days of follow-up (Figs. 2C and D).
Impact of SHIV infection on distribution of naïve and memory
CD4+ T cell populations
Dynamics of naive and memory CD4+ T cell populations
were followed in three SHIVsf162p3 infected (DT54, L274 and
FA87) and two uninfected (AA41 and T887) macaques. In
infected macaques, there was a modest, selective depletion of
absolute numbers of central memory (CD28+CD95+) CD4+ T
cells from day 0 (484) to day 14 (278) which persisted through
day 21 p.i. Absolute counts of central memory increased after
21 p.i., but remained lower compared to baseline. In contrast,
mean numbers of effector memory (CD28−CD95+) CD4+ T
cells remained stable from day 0 (146/μl of blood) to day 28 p.i.
(131/μl of blood) but decreased in later time points (Fig. 3A).
Naïve (CD28+CD95−) CD4+ T cells remained stable with mean
values ranging from 182 to 320/μl of blood.
In contrast, uninfected macaques (n=2) maintained consis-
tent levels of memory cell populations throughout this study
(Fig. 3B). The mean counts of central memory and effector
memory ranged from 388 to 591 and 39 to 70/μl of blood
respectively. Interestingly, the animals that did not get infected
also had higher absolute counts of naive CD4+ T cells before
infection compared to animals that became infected (Fig. 3), butwith so few animals followed, the significance of this finding is
uncertain.
T cell proliferation
The same 5 macaques (3 infected and 2 uninfected) were
examined for Ki67 (proliferation antigen) expression. Increased
proportions of CD4+CD95+ and CD8+CD95+ T cells expres-
sing Ki67 were detected in SHIVsf162p3 infected macaques
compared to uninfected macaques (Fig. 4A). An increased level
of T cell proliferation was detected in both memory CD4 and
CD8 T cells (5.5 vs. 11% and 4.8 vs. 21.8% for CD4 and CD8 T
cells respectively for day 0 to day 21 p.i.) from all three infected
macaques (DT54, L274 and FA87) examined. By day 70 p.i.,
the expression of Ki67 by memory T cells returned to baseline
levels. Mean increases in Ki67 expression were significantly
increased in infected animals compared with uninfected
controls at day 21 p.i. (Figs. 4A and B).
To correlate CD4/CD8 T cell proliferation with plasma viral
load, a linear regression analysis was performed. In all 3
SHIVsf162p3 infected macaques, CD8 proliferation positively
correlated with plasma viremia (r2 ranged from 0.58 to 0.75,
P value 0.005–0.029). However, CD4+ T cell proliferation
correlated with viral load in only one macaque (DT54; r2 =0.85,
p=0.001). The other two (FA87 and L274) had either low
(r2 =0.31) or no correlation with CD4 T cell proliferation and
viral load.
Antigen-specific cytokine responses
We investigated the potential association between plasma
viral load and antigen-specific cytokine responses in all
SHIVsf162p3 inoculated macaques. Representative CFC results
for TNF-α and IFN-γ production by peptide specific CD8+ T
cells are shown from an SHIVsf162p3 infected macaque (L274)
Fig. 2. Absolute counts (top) and percentages (bottom) of CD4 and CD8 lymphocytes in peripheral blood of SHIVsf162p3 infected (A and B) (n=10) and uninfected (C
and D) (n=3) macaques. Data presented are means±standard errors of CD4+ and CD8+ T cells at different time points of infection.
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infected, and virus-specific T cell responses were followed
using ELISPOT for IFN-γ responses and CFC for TNF-αFig. 3. Absolute counts of naive (CD28+CD95−), central memory (CD28+CD95+) a
SHIVsf162p3 infected (A) and uninfected (B) macaques after inoculation. Six-color flowresponses to Tat, Gag and Env were examined (Fig. 6). One
macaque (EV63) did not become infected as determined by
consistent inability to detect plasma viremia and antigen-nd effector memory (CD28−CD95+) CD3+ CD4+ T cells in peripheral blood of
cytometry was performed to define the cell populations as described in Table 3.
Fig. 4. (A) T cell proliferation assessed by %Ki67 expression is shown for CD4+ and CD8+ T cells. Both CD4+ and CD8+ T cell proliferation increased following
SHIVsf162p3 infection between 14 and 35 days post inoculation, but returned to baseline levels thereafter. (B) Representative expression of CD95 and Ki67 in CD4
+ and
CD8+ T cells in blood from an SHIVsf162p3 infected macaque (DT54). Percentages of Ki67
+ CD95+ T cells in either CD4+ or CD8+ T cells are shown in the box of each
dot plot. Six-color flow cytometry staining was performed to define proliferating T cells as described in Table 3.
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shown). Individual virus-specific cytokine responses in relation
to plasma viral load in each macaque are shown in Fig. 6.
In the second experiment, virus-specific combined IFN-γ and
TNF-α responses to Tat, Gag, Env and Nef were examined by
CFC alone in a group of 3 vaginally infected macaques (DT54,
L274 and FA87). The individual CFC responses to all peptidepools in relation to plasma viremia for these animals are shown
in Fig 7. Two macaques simultaneously challenged with this
group (AA41 and T887) did not become infected and never had
detectable antigen-specific cytokine responses throughout the
course of the study (data not shown).
Overall, positive CFC responses were detected in 9 out of 10
infected animals examined using a CFC assay (Figs. 6 and 7)
Fig. 5. Intracellular cytokine flow cytometry for IFN-γ and TNF-α responses from a representative SHIVsf162p3 infected macaque (L274). PBMC were unstimulated
(medium control) or stimulated for 6 h with different peptide pools at day 56 post inoculation. Cells were gated first on lymphocytes followed by CD3+ and then on
CD8+ T cells. The percentages of IFN-γ and/or TNF-α positive cells are shown in each quadrant. Bold numbers represent positive responses. Four-color CFC staining
was performed to define antigen-specific cytokine responses as described in Table 3.
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had a positive response by the ELISPOT IFN-γ assay (Fig. 6).
Interestingly, positive responses were consistently detected ear-
lier by the CFC assay as compared to the ELISPOT technique as
4 of the 10 infected macaques (AK46, EV46, L274 and FA87)
had TNF-α responses to Gag peptide pools 14 days after infec-
tion, and another two (DT55, EV50) had positive responses by
21 days of infection (Figs. 6 and 7). In contrast, of the seven
infected animals examined by the ELISPOT IFN-γ assay, only
one (DK46) had a detectable response prior to 28 days of
infection (Fig. 6). In fact, the apparent greater sensitivity of the
CFC assay was one reason why the ELISPOT technique was
replaced by a two-cytokine CFC assay in the second series of
experiments.
In all, nine of ten infected macaques (all except DT54) had
detectable TNF-α responses by either CD4+ or CD8+ T cells at
some time point (Table 1). The percentage of TNF-α+ responses
ranged from 0.05–0.23, 0.04–5.79, 0.04–0.21 to 0.06–1.03 for
Tat, Gag, gp120 and gp41 Env peptide pools respectively. In
general, most of the TNF-α responses were from CD8+ T cells,
but in two macaques (AK46 and EV46), the earliest TNF-α
responses were detected in CD4+ T cells (Table 1). Two
macaques (AK46, DT55) demonstrated strong or persistent
TNF-α responses at multiple time points after infection.
However, three macaques (AJ61, DT91 and EV47) only had aFig. 6. Plasma viral loads (line graphs) compared with SHIV-peptide specific T cell res
ELISPOT responses (IFN-γ SFC/1×106 cells) are shown in the left after stimulat
percentages of different antigen-specific TNF-α+ T cells responding to peptide pools a
only positive responses are shown. Note that, while some animals (AK46, EV50) ha
minimal responses, yet most animals have marked reductions in viral loads by 21 da
tested.single detectable TNF-α response after infection. These animals
had only one positive response to either gp120 (AJ61), Tat
(DT91) or Gag (EV47) at day 42 p.i. with no positive responses
to any other peptide throughout the course of infection. Gag
peptides were found to be the dominant antigen in inducing
TNF-α responses, followed by Env and Tat peptides (Table 2).
Assays for testing Nef responses were only performed in the
second group of animals, but one (DT54) of the three macaques
tested had strong and persistent anti-Nef responses from day 14
through day 56 p.i. (Fig. 7). Finally, double positive (TNF-α+
and IFN-γ+CD8+) T cell responses were detected in one of these
three animals (L274) at day 28 and 56 post-infection, but no
double positive responses were detected in the other two
animals at any time point (data not shown).
IFN-γ ELISPOT responses in the 7 infected macaques
tested using this technique ranged from 55 to 155 and from
52 to 315 SFC/106 PBMC for Gag and Env peptide pools
respectively (Fig. 6). No Tat specific IFN-γ responses were
detected by ELISPOT in any animal at any time point. In 4
macaques (AJ61, AK46, EV46 and EV47), Gag peptides
were the dominant antigens responsible for eliciting virus-
specific IFN-γ responses by ELISPOT (Table 2). In two
macaques (EV46 and EV47), anti-Gag responses were detect-
able only at one (d 42) or two (d 28 and 56) time points (Fig. 6)
by ELISPOT.ponses in seven SHIVsf162p3 infected macaques following intravaginal infection.
ion with Tat, Gag and Env peptide stimulation (symbols). CFC data showing
re shown in the right panels. Although all peptides were tested at each time point,
ve persistent cellular responses to multiple peptides, other animals (DT91) have
ys of infection, regardless of the frequency or magnitude of cytokine responses
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Fig. 7. Plasma viral loads in relation to SHIV-specific T cell responses in three SHIVsf162p3 infected macaques after intravaginal infection. Panels were generated using
CFC data and show plasma viral load (lines) compared with IFN-γ and TNF-α+ T cell responses after Tat, Nef, Gag and Env peptide stimulation (symbols). Although
all peptides were tested at each time point, only positive responses are shown.
42 B. Pahar et al. / Virology 363 (2007) 36–47One macaque (DT55) that never had a positive IFN-γ
ELISPOT response had strong and persistent TNF-α responses
by CFC (Fig. 6). Conversely, macaque DT54 had no TNF-α
responses, yet strong and persistent IFN-γ responses by CFC
analysis (Fig. 6). Despite these exceptions, macaques with
strong ELISPOT responses often had strong CFC responses
(AK46, EV50) and weak responders by ELISPOT were also
often weak by the CFC assay (DT91, EV47). However, note
that macaque (AK46) had both strong and persistent IFN-γ
and TNF-α responses, yet this was the animal with the highest
viremia through 84 days of infection (Fig. 6). Using a
Spearman rank correlation test, there was a positive correlation
between viral load and Gag antigen-specific TNF-α responses
(p=0.01, r=0.79) in this macaque. Conversely, macaque
DT91 had no positive ELISPOT responses and only a single
weak Tat response at day 42 p.i., yet this animal effectively
controlled viremia by 84 days p.i. Statistical analyses
comparing the breadth and magnitude for all individual
peptides as well as Tat, Nef, Gag and Env responses combined
failed to detect a statistically significant correlation with
plasma viral loads and antigen-specific cytokine responses in
infected macaques.Discussion
In our experience, rhesus macaques of Chinese origin
vaginally infected with relatively low doses (300 TCID50) of
SHIVsf162p3 initially have high viral loads in primary infection,
but in approximately 90% of animals, this is followed by low to
intermittently undetectable plasma viremia within 70–90 days
after infection. The purpose of this study was to determine if
there was a correlation between this early decline in plasma
viremia and the emergence or magnitude of virus-specific TNF-
α or IFN-γ responses to Tat, Nef, Gag or Env peptide pools
using either ELISPOT or CFC techniques. Our hypothesis was
that the emergence of antigen-specific cytokine responses
would correlate with the control of virus in the blood in this
model. However, no such correlation could be detected in this
study, at least with the techniques used.
Although a positive correlation between viral load and
peptide specific cytokine responses was detectable in one
animal, the frequency or magnitude of antigen-specific
responses did not positively correlate with control of viral
loads in any animal (Fig. 6). Nine out of ten infected macaques
was able to effectively control plasma viral loads within 70 days
Table 2
Total number of SHIVsf162p3 infected animals with detectable SIV/HIV cytokine
responses in the blood based with either ELISPOT or CFC assays
Cytokines Tat Nef Gag gp120 gp41
IFN-γ 1/10 1/3 6/10 4/10 4/10
TNF-α 4/10 0/3 7/10 5/10 5/10
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copies/ml) plasma viral loads by this time point, yet this control
was not associated with a clear pattern of virus-specific immune
responses (Figs. 6 and 7). Moreover, the single Indian origin
macaque had the most prominent immune responses of all
animals, yet had higher viral loads post peak than all but one
other animal through at least 56 days after infection (Fig. 6).
The comprehensive approach in this study showed that
peptides from all the major SHIV proteins may serve as targets
for SHIV-specific CD8+/CD4+ T cells and that infected animals
had a remarkable breadth and magnitude of virus-specific T cell
responses. These data clearly emphasize that the response to a
single epitope is not predictive of the total T cell responses in an
infected animal, at least in this model system. Clearly the
ELISPOT IFN-γ assay alone was not predictive of the decline
in viral loads as at least two animals (DT55 and DT91) were
completely negative for virus-specific responses at all time
points by ELISPOT, despite comparable reductions in viral
loads to other macaques with responses (Fig. 6). Although the
emergence of cytokine responses correlated with the decline in
viral load in some macaques, overall, neither the breadth,
specificity nor the magnitude of virus-specific T cell responses
correlated with reductions in plasma viral loads. Although it
could be argued that 6 animals (AK46, DT55, EV50, DT54,
FA87 and L274) had strong and persistent cytokine responsesTable 1
SHIV-specific TNF-α+ T cell responses of SHIVsf162p3 infected rhesus
macaques a
Monkey Peptide
pools
T cell
phenotype
Days post inoculation
0 7 14 21 28 42 56 70
AJ61 gp120 CD8 0.09
AK46 Tat CD8 0.13 0.23 0.05 0.09
Gag CD4 0.07
CD8 0.11 0.08 0.12 0.06
gp120 CD8 0.21
DT55 Tat CD4 0.1
Gag CD4 0.09 0.14
CD8 0.04 0.1
gp120 CD4 0.08
CD8 0.16 0.04 0.09
gp41 CD4 0.08
CD8 0.09 0.11
DT91 Tat CD4 0.05
EV46 Gag CD4 0.06
CD8 0.06 0.06
gp41 CD8 0.06
EV47 Gag CD4 0.06
EV50 Tat CD4 0.04
Gag CD8 0.65
gp120 CD8 0.05
gp41 CD8 0.12
L274 Gag CD8 0.11 0.91
gp120 CD8 0.14
gp41 CD8 0.3 1.03
FA87 Tat CD8 0.11
Gag CD8 0.10 0.13 5.79
gp41 CD8 0.13
a Peptide-specific responses are reported for CD3+/CD4+ or CD3+/CD4−
(CD8+) T cell subsets. Although all peptide pools (Tat, Nef, Gag and Env) were
tested, only positive responses are shown.by either ELISPOT or CFC assay, four animals (AJ61, DT91,
EV46 and EV47) had minimal or delayed antigen-specific
cytokine responses that were not detectable until after the
decline in viremia. These findings are in agreement with a
recent study in HIV-1-infected individuals (Addo et al., 2003).
A similar lack of correlation has also been described between
control of viral loads in HIV-1-infected patients and HIV-
specific CD4+ and CD8+ T cell responses (Betts et al., 2001;
Dalod et al., 1999). However, others have reported inverse
correlations between HIV-1-specific CD8+ T cell responses and
viral loads (Betts et al., 1999; Ogg et al., 1998; van Baalen et al.,
1997). In the current study, antigen-specific cytokine responses
were detected as early as day 14 (4/10 macaques) and in the
majority by day 21 (7/10 macaques) in SHIVsf162p3 infected
Chinese rhesus macaques, which is in agreement with a recent
study of SHIVsf162p3 infection in pig tail macaques (Macaca
nemestrina) using similar assays for detecting cytokine
responses to peptides (Batten et al., 2006). However, in the
latter study, peak responses were detected at 2.5 weeks post-
infection, a time point that was not examined in the current
study. In addition, only 3 of 8 pigtailed macaques cleared
SHIVsf162p3 infection whereas 9 of 10 Chinese macaques
controlled infection in the current study. However, the
differences in viral persistence could be attributed to the
differences in the species of animal used and/or in the higher
dose of the inoculum used in the pigtail macaques, so these
results are difficult to directly compare.
Another recent study by Trunova et al. compared cellular
immune responses (by ELISPOT) in Indian origin rhesus
macaques intravaginally inoculated with combinations of both
SHIVsf162p3 (an R5 virus) and SHIVSF33A (an X4 virus)
between animals inoculated with and without Depo-Provera
pre-treatment (Trunova et al., 2006). This study demonstrated
higher peak and early viral loads, as well as delayed antiviral
cellular immune responses in Depo-Provera treated macaques
as compared to animals inoculated with higher doses of the
same viruses without pre-treatment with Depo-Provera. The
results suggested that this progestin-based contraceptive
suppressed cellular immune responses resulting in the
increased peak and acute viral loads (Trunova et al., 2006).
Although the macaques in the current study were administered
Depo-Provera to increase rates of transmission, again, these
data are difficult to compare directly, particularly since
animals in the previous study were of Indian origin and dual
infected. Regardless, it may be argued that the use of Depo-
Provera in the current study delayed or suppressed cellular
immune responses in these animals. However, the fact that
viral loads still significantly declined post peak viremia,
despite weak to absent immune responses in most animals at
44 B. Pahar et al. / Virology 363 (2007) 36–47these time points, further supports the absence of a correlation
between the post peak decline and emergence of cellular
immune responses, at least as measured in this study. The data
presented here indicate that, on an individual basis, no specific
correlation could be detected between the decline in plasma
viremia and emergence or magnitude of a specific cellular
immune response in the blood of Chinese origin macaques.
In our study, the most frequent responses detected were to
SIV-Gag, with up to 70% of macaques recognizing this peptide
pool, followed by responses to gp120, gp41 and, lastly, Tat
peptides. The major antigen-specific cytokine producing cells
were CD8+ with significantly fewer virus-specific responses by
CD4+ T cells. However, the variability and weak nature of the
specific cytokine responses detected in most macaques showed
no obvious correlation with the post peak decline in plasma viral
load.
An analysis of peripheral blood T cell subsets in 3 macaques
in this study revealed that the virus was selectively targeting
central memory CD4+ T cells resulting in modest depletion of
this subset. Like HIV and SIV, SHIVsf162p3 clearly utilizes
CCR5 as its major coreceptor for infection of cells. It is now
known that CCR5-tropic SIVs selectively deplete memory
CD4+ T cells as CCR5 expression is largely restricted to
memory T cells (Cromwell et al., 2000; Mattapallil et al., 2005;
Picker et al., 2004; Veazey et al., 2003b). In contrast, naive
CD4+ T cells, which lack CCR5 expression, appear to escape
destruction in acute/early CCR5-tropic SIV infection, even in
animals with high viral loads that progress rapidly to AIDS
(Picker et al., 2004).
An increase of CD4+ and/or CD8+ T cell proliferation (Ki67
expression) was also detected beginning ~2–3 weeks after
infection, which is in agreement with the observations of others
(Kaur et al., 2000; Monceaux et al., 2003; Picker et al., 2004;
Rosenzweig et al., 1998). Increased Ki67 expression was higher
in memory subsets of CD4+ and/or CD8+ T cells and since there
was no depletion of CD8+ T cells, this suggests that this
response was induced by infection-mediated immune stimula-
tion, rather than a homeostatic response to T cell depletion.
Proliferating memory CD8+ T cells might be playing an
important role in controlling viral replication regardless of the
loss of CD4+ T cells. However, using ELISPOT and CFC
methods to detect TNF-α and/or IFN-γ responses to Tat, Nef,
Gag and Env peptide pools alone, we could not identify a
correlation between virus-specific cytokine responses and the
post peak decline in plasma viremia in this animal model.
We have previously hypothesized that the peak viremia and
subsequent decline in plasma viral loads following primary
SIV/HIV infection is the result of initial infection of, and
subsequent depletion of, the large numbers of optimal viral
target cells (memory CD4+CCR5+ T cells) that reside in the
mucosal tissues of normal, uninfected patients (Veazey et al.,
2001). Like HIV (Brenchley et al., 2004; Mehandru et al., 2004)
and SIV (Li et al., 2005; Mattapallil et al., 2005; Veazey et al.,
2000), infection with SHIVsf162p3 has been shown to rapidly
deplete intestinal CD4+CCR5+ T cells in macaques (Harouse et
al., 1999) which may also result in the post peak decline in viral
loads in blood.However, although we did not detect a direct correlation
between declining plasma viremia and cytokine responses in
this study, this does not rule out the possibility that CTL
responses play a role in the post peak decline in plasma viremia.
We only examined a limited number of virus-specific immune
responses and also did not examine responses to accessory
proteins such as Vif, Pol or Rev. This could be important
particularly in the case of Chinese origin macaques because,
unlike Indian origin macaques, the dominant MHC responses
for Chinese macaques are still unknown. However, these data
suggest that at least in this race of macaques, IFN-γ and TNF-α
responses to Tat, Nef, Gag and Env do not correlate with the
early reduction in plasma viremia.
Additional other explanations for the reduction in post peak
viral loads include the development of cellular immune
responses in tissues other than the peripheral blood, particularly
the intestine and other mucosal sites. In fact, a recent vaccination
study demonstrated a better correlation with protection with
mucosal rather than systemic CTL responses (Belyakov et al.,
2006). Still other possible explanations for the early reductions
in viremia in this model include induction of immune responses
by effector cells not detected in these assays, such as perforin
expressing cells, IL-2 responses, MIP-1β responses or others.
For example, recent studies of HIV-infected nonprogressors
suggest that polyfunctional Tcell responses (i.e., simultaneously
measuring degranulation, IL-2, TNF-α, IFN-γ and MIP-1β)
provide a better correlation with decreased viremia and
protection from disease progression (Betts et al., 2006).
However, using the assays described here (ELISPOT and/or
1–2 cytokine flow cytometry) on peripheral blood lymphocytes,
the results clearly demonstrate that neither IFN-γ nor TNF-α
production by CD4+ or CD8+ T cells alone correlates with
control of viremia in early SHIVsf162p3 infection of rhesus
macaques of Chinese origin.
Materials and methods
Animals and virus
Twelve adult female Chinese and one Indian (AK46) origin
rhesus macaques (Macaca mulatta) between 5 and 15 years of
age were examined in this study. Blood from additional naive,
uninfected macaques was often collected from other animals for
controls. All animals were housed at the Tulane National
Primate Research Center in accordance with the guidelines from
the American Association for Accreditation of Laboratory
Animal Care. All experiments were reviewed and approved by
the Tulane University Institutional Animal Care and Use
Committee. These animals were healthy and free from SIV,
STLV and Type D retrovirus at the time of inoculation. In two
separate experiments, all thirteen adult macaques were treated
with Depo-Provera (30 mg intramuscularly) and 4 weeks later
inoculated vaginally with 300 TCID50 SHIVsf162p3 virus as
previously described (Veazey et al., 2003a). All macaques used
in this study were sham-inoculated controls for microbicide
studies. Virus was obtained through the AIDS Research and
Reference Reagent Program, NIAID, thawed and diluted in
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inoculation.
Eight macaques were initially challenged with virus (7 of
which became infected) and followed using 4-color flow
cytometry and ELISPOT and CFC assays for detecting
antigen-specific IFN-γ and TNF-α Tcell responses respectively.
Heparinized and EDTA anticoagulated blood were collected at
days 0, 7, 14, 21, 28, 35, 42, 56, 70 and 84 post viral inoculation.
The remaining five macaques (three of which became
infected) were followed by 6-color flow cytometry for
immunophenotyping and cytokine flow cytometry (CFC) for
simultaneously detecting antigen-specific IFN-γ and TNF-α
cytokine responses.
Preparation of PBMC
For ELISPOT and cytokine flow cytometry assays, PBMC
were isolated from heparinized whole blood by density gradient
centrifugation (Lymphocyte Separation Medium, ICN Biome-
dicals, Ohio) as described elsewhere (Pahar et al., 2003).
Quantitation of plasma viral RNA
Viral RNA in plasma was quantified by a bDNA signal
amplification assay, version 4.0, specific for SIV, from Bayer
Inc., which has a threshold detection limit of 125 viral copies
per ml plasma (Veazey et al., 2003a).
T cell phenotyping by four- and six-color flow cytometry
For cell surface staining, 150 μl of EDTA whole blood was
stained with directly conjugated mAbs (listed in Table 3), using
a whole blood lysis staining protocol (Veazey et al., 2003a).
After staining, cells were fixed with 1% paraformaldehyde
(Sigma) in PBS.
For Ki67 (intracellular) staining, cells were surface stained,
washed, fixed and permeabilized with 1× fixation/permeabili-
zation solution (BD Biosciences) for 10 min (Pahar et al., 2006;
Pitcher et al., 2002). Following two washes with Dulbecco's
PBS containing 0.1% BSA (dPBS/BSA) buffer, the cells were
stained with anti-Ki67 mAb for 30 min at room temperature and
finally resuspended in 1% paraformaldehyde solution.
Acquisition of data was performed using either a FACS
Calibur or FACSAria Flow Cytometer using Cell Quest andTable 3
Antibodies and fluorochromes used for immunophenotyping T cells and intracellula
Panel FITC a PE PerCP/PE-
Immunophenotyping
A (Clone) CD20 (L27) CD3 (SP34) CD8 (SK1
B (Clone) CD3 (SP34) Ki67 (B56) CD95 (DX
CFC staining
C (Clone) IFN-γ (4S.B3) TNF-α (Mab11) CD3 (SP34
D (Clone) TNF-α (Mab11) CD69 (FN50) CD3 (SP34
a All monoclonal antibodies except CD8 PE-Texas Red (Caltag Lab, CA) were c
conjugated from BD Biosciences.FACSDiva software (BD Biosciences) respectively. Cells were
gated through CD3+ “bright” T lymphocytes and at least 20,000
total events were collected from each sample. Data were
analyzed using FlowJo software v. 6.0 (TreeStar). Absolute
count of different phenotypic cell population was calculated
based on CBC count and flow cytometry data.
Cytokine flow cytometry (CFC) assay
A CFC assay was employed to detect either CD3+/CD4+ or
CD3+/CD4− (CD8+) T lymphocytes that produce either IFN-γ
and/or TNF-α in response to antigen-specific stimulation as
discussed previously (Pahar et al., 2003; Waldrop et al., 1997).
Briefly, fresh heparinized PBMC were resuspended at 1×106
cells/ml and stimulated with different peptide pools (HIV-Tat,
SIV-Nef, Gag and Env of SHIV) at a final concentration of 1 μg/
ml of each peptide. Peptides (15-mers with 11 amino acids
overlap) derived from the HIV Tat, SIV-Nef, Gag and
SHIVsf162p3 Env were obtained from NIH AIDS Research and
Reference Reagent Program. Peptide pools were prepared so
that each protein was equally represented in the pool. One
peptide pool was made for each HIV Tat (peptide 1–23) and
SIV-Nef (peptide 1–64) peptides. Three peptide pools (GagA:
peptide 1–33; GagB: peptide 34–69; GagC: peptide 70–125)
were made to encompass the entire Gag region of SIV. Similarly
four peptide pools (EnvA: peptide 1–60; EnvB; peptide 61–
124; EnvC: peptide 125–168; EnvD: peptide 169–211) were
prepared to encompass the entire Env region of SHIVsf162p3. For
positive controls PMA (50 ng/ml) and Ionomycin (1 μg/ml)
were used. Negative controls had no antigen/mitogen stimula-
tion. Co-stimulatory antibodies anti-CD28 (clone CD28.2,
Pharmingen) and anti-CD49d (clone 9F10, Pharmingen) were
added at 1 μg/ml in all the tubes including positive and negative
controls. Brefeldin A (10 μg/ml, Sigma) was added to cultures
after the first hour, in a 6 h incubation period. Following
stimulation, the cells were stained first for surface staining and
then for intracellular markers (listed in Table 3) and finally
resuspended in 1% paraformaldehyde as described earlier
(Pahar et al., 2005, 2006).
Data were acquired using a FACS Calibur flow cytometer
and Cell Quest software (BD Immunocytometry Systems).
5×104 CD3+/CD4+ events were acquired for each sample and
data analysis was performed using FlowJo software (TreeStar
Inc.) version 6.0. Gated CD3+ cells were analyzed as CD4+ andr cytokine flow cytometry
Cy5 PE-TR APC Alexa 405
) – CD4 (L200) –
2) CD8 (MHCD0817) CD28 (28.2) CD4 (L200)
) – CD4 (L200) –
) – CD4 (L200) –
ommercially obtained from BD Biosciences, CA. CD4-Alexa-405 was custom
46 B. Pahar et al. / Virology 363 (2007) 36–47CD4− (CD8+) T cells, and the percentage of CD69+/TNF-α+ or
TNF-α+/IFN-γ+ cells was calculated for both. Criteria for
positive responses were determined based on the percentage of
cytokine responses obtained from SIV seronegative animals,
which were included in each experiment. For IFN-γ, the criteria
for a positive response were determined when the frequency
was at least twice that of the media control culture and greater
than 0.05% or the presence of a distinct population cluster of
IFN-γ+ bright cells. Since high frequencies of TNF-α positive
cells were occasionally observed in media control cultures, a
positive response for TNF-α was defined as a two-fold increase
in antigen stimulated cultures above the control.
ELISPOT assay
The number of antigen-specific IFN-γ spot forming cells
(SFC) in rhesus monkeys was measured with a commercial
ELISPOT assay specific for rhesus IFN-γ (U-Cytech, Utrecht,
The Netherlands). This assay was performed using fresh
heparinized PBMC as previously described (Pahar et al.,
2003; Van Rompay et al., 2004). Peptide pools of overlapping
peptides (as described for CFC assay) from HIV-Tat, SIV-Gag
and Env region of SHIVsf162p3 were also used for this study.
Pooled peptides were added to cells at a final concentration of 1
μg/ml for each individual peptide.
The numbers of spot forming cells were counted using the
KS ELISPOT system (Zellnet Consulting Inc.). The mean
number of spots per duplicate or triplicate well was calculated
and the results were considered positive if the number of SFC
for 2×105 cells was≥10 per well and greater than two-fold that
of the negative control (medium only) wells plus 2 standard
deviations.
Statistical analysis
Graphical presentation and statistical analysis of the results
were performed by using the GraphPad Prism 4.0 (GraphPad
Software Inc., San Diego, CA). Correlation between viral loads
and antigen-specific cytokine responses was determined using
Spearman rank correlation test and an analysis of variance
(ANOVA) using Prism software. Statistical comparison of viral
load and peptide responses was performed for both individual
peptides as well as the combined peptide responses in each
animal. Difference in CD4 counts, phenotype etc. were
compared by Student's t test. For all statistical analysis, results
were considered significant if probability was <0.05 (i.e.,
p<0.05).
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